• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转谷氨酰胺酶抑制剂加合物的固态13C核磁共振研究

Solid-state 13C NMR study of a transglutaminase-inhibitor adduct.

作者信息

Auger M, McDermott A E, Robinson V, Castelhano A L, Billedeau R J, Pliura D H, Krantz A, Griffin R G

机构信息

Francis Bitter National Magnet Laboratory, Massachusetts Institute of Technology, Cambridge 02139.

出版信息

Biochemistry. 1993 Apr 20;32(15):3930-4. doi: 10.1021/bi00066a012.

DOI:10.1021/bi00066a012
PMID:8097108
Abstract

We have used solid-state 13C NMR to study the structure of the adduct resulting from the inactivation of the enzyme transglutaminase by 3-halo-4,5-dihydroisoxazoles. These inhibitors were conceived on the assumption that they would inhibit transglutaminase by attack of an enzyme active site cysteine thiol on the imine carbon of the dihydroisoxazole ring. The tetrahedral intermediate formed could then break down with the loss of the halide group and the subsequent formation of a stable imino thioether adduct. We have compared the 13C CPMAS spectra of the chloro-, bromo-, and (ethylthio)dihydroisozazole inhibitors, and the results indicate that the chemical shift of the C-3 carbon is sensitive to the nature of the heteroatom. Subtraction of the natural-abundance 13C solid-state NMR spectrum of the enzyme from that of the enzyme inactivated by C-3-labeled chlorodihydroisoxazole reveals a broad peak at 156 ppm. The chemical shift of this peak is very close to that observed for a model 3-ethylthio compound and suggests the formation of a stable imino thioether enzyme adduct. Similar results were obtained for lyophilized enzyme adducts and for frozen solutions of the enzyme adduct in the absence and presence of Ca2+. We have also compared these results with those obtained by solution NMR on an aqueous solution of the enzyme-inhibitor complex. The 13C-labeled C-3 resonance was not observed in this case.

摘要

我们已使用固态¹³C核磁共振技术来研究由3-卤代-4,5-二氢异恶唑使转谷氨酰胺酶失活所产生的加合物的结构。这些抑制剂是基于这样的假设设计的,即它们会通过酶活性位点的半胱氨酸硫醇对二氢异恶唑环的亚胺碳的攻击来抑制转谷氨酰胺酶。然后形成的四面体中间体可以随着卤化物基团的离去而分解,并随后形成稳定的亚氨基硫醚加合物。我们比较了氯代、溴代和(乙硫基)二氢异恶唑抑制剂的¹³C交叉极化魔角旋转(CPMAS)谱,结果表明C-3碳的化学位移对杂原子的性质敏感。从用C-3标记的氯代二氢异恶唑失活的酶的¹³C固态核磁共振谱中减去酶的天然丰度¹³C固态核磁共振谱,在156 ppm处显示出一个宽峰。该峰的化学位移与模型3-乙硫基化合物观察到的非常接近,表明形成了稳定的亚氨基硫醚酶加合物。对于冻干的酶加合物以及在有无Ca²⁺存在下的酶加合物的冷冻溶液,也获得了类似的结果。我们还将这些结果与通过溶液核磁共振在酶 - 抑制剂复合物的水溶液上获得的结果进行了比较。在这种情况下未观察到¹³C标记的C-3共振。

相似文献

1
Solid-state 13C NMR study of a transglutaminase-inhibitor adduct.转谷氨酰胺酶抑制剂加合物的固态13C核磁共振研究
Biochemistry. 1993 Apr 20;32(15):3930-4. doi: 10.1021/bi00066a012.
2
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.二氢异恶唑对转谷氨酰胺酶2的选择性抑制作用的构效关系分析
J Med Chem. 2006 Dec 14;49(25):7493-501. doi: 10.1021/jm060839a.
3
Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2.用于标记和可视化催化活性转谷氨酰胺酶2的二氢异恶唑类似物。
Chem Biol. 2011 Jan 28;18(1):58-66. doi: 10.1016/j.chembiol.2010.11.004.
4
A study of the stabilization of tetrahedral adducts by trypsin and delta-chymotrypsin.一项关于胰蛋白酶和δ-胰凝乳蛋白酶对四面体加合物稳定性影响的研究。
Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):889-900. doi: 10.1042/bj2860889.
5
3-hydroxy-3-methylglutaryl-coenzyme A synthase reaction intermediates: detection of a covalent tetrahedral adduct by differential isotope shift 13C nuclear magnetic resonance spectroscopy.3-羟基-3-甲基戊二酰辅酶A合酶反应中间体:通过差分同位素位移13C核磁共振光谱法检测共价四面体加合物
Biochemistry. 2000 Mar 28;39(12):3360-8. doi: 10.1021/bi9922897.
6
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.二氢异恶唑衍生物的化学与生物学:人转谷氨酰胺酶2的选择性抑制剂
Chem Biol. 2005 Apr;12(4):469-75. doi: 10.1016/j.chembiol.2005.02.007.
7
Adenosine deaminase converts purine riboside into an analogue of a reactive intermediate: a 13C NMR and kinetic study.腺苷脱氨酶将嘌呤核糖核苷转化为反应中间体类似物:一项碳-13核磁共振及动力学研究。
Biochemistry. 1987 Dec 15;26(25):8450-7. doi: 10.1021/bi00399a063.
8
Solid state 13C NMR of 30-crown-10 ether and 30-crown-10.4H2O.30-冠-10醚和30-冠-10·4H₂O的固态¹³C核磁共振
Solid State Nucl Magn Reson. 2001 Nov-Dec;20(3-4):137-44. doi: 10.1006/snmr.2001.0038.
9
Solid-state 13C NMR detection of a perturbed 6-s-trans chromophore in bacteriorhodopsin.细菌视紫红质中受扰的6-s-反式发色团的固态13C核磁共振检测
Biochemistry. 1985 Nov 19;24(24):6955-62. doi: 10.1021/bi00345a031.
10
Adducts of rhodium(II) tetraacetate with some nitrogenous organic ligands: application of natural abundance 15N and 13C CPMAS NMR spectroscopy.四乙酸铑(II)与一些含氮有机配体的加合物:天然丰度15N和13C交叉极化魔角旋转核磁共振光谱的应用
Solid State Nucl Magn Reson. 2007 Oct;32(2):25-33. doi: 10.1016/j.ssnmr.2007.07.005. Epub 2007 Aug 13.

引用本文的文献

1
Lysozyme is Sterically Trapped Within the Silica Cage in Bioinspired Silica-Lysozyme Composites: A Multi-Technique Understanding of Elusive Protein-Material Interactions.溶菌酶在仿生硅基溶菌酶复合材料的硅笼中受到空间位阻:对难以捉摸的蛋白质-材料相互作用的多种技术理解。
Langmuir. 2022 Jul 5;38(26):8030-8037. doi: 10.1021/acs.langmuir.2c00836. Epub 2022 Jun 23.
2
Facing and Overcoming Sensitivity Challenges in Biomolecular NMR Spectroscopy.面对并克服生物分子核磁共振光谱中的灵敏度挑战
Angew Chem Int Ed Engl. 2015 Aug 3;54(32):9162-85. doi: 10.1002/anie.201410653. Epub 2015 Jul 1.
3
Practical considerations over spectral quality in solid state NMR spectroscopy of soluble proteins.
可溶性蛋白质固态 NMR 光谱学中光谱质量的实际考虑因素。
J Biomol NMR. 2013 Oct;57(2):155-66. doi: 10.1007/s10858-013-9776-0. Epub 2013 Aug 30.
4
Transglutaminase activation in neurodegenerative diseases.神经退行性疾病中的转谷氨酰胺酶激活
Future Neurol. 2009 Jul 1;4(4):449-467. doi: 10.2217/fnl.09.17.
5
Transglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae.转谷氨酰胺酶催化反应对盘尾丝虫第三期幼虫的蜕皮很重要。
Antimicrob Agents Chemother. 1995 Sep;39(9):1913-9. doi: 10.1128/AAC.39.9.1913.
6
The blind watchmaker and rational protein engineering.盲眼钟表匠与理性蛋白质工程
J Biotechnol. 1994 Aug 31;36(3):185-220. doi: 10.1016/0168-1656(94)90152-x.